How Much Did RYAM Raise?
Funding & Key Investors

RYAM, a global leader in cellulose-based technologies, has secured significant enterprise-level funding, with its most recent capital infusion totaling $39M. This latest round follows a history of substantial investment, bringing the company's total funding to $70.5M. The recent financing underscores RYAM's strategic importance in the biomaterials sector.

What is RYAM?

RYAM
ManufacturingPulp & PaperChemicals & Related Products

RYAM specializes in high-purity cellulose specialties, a natural polymer essential for a wide array of applications including filters, food, pharmaceuticals, and various industrial uses. The company leverages specialized assets to produce world-leading high-purity cellulose, alongside biofuels, bioelectricity, and other biomaterials such as bioethanol and tall oils. This focus positions RYAM at the forefront of sustainable material innovation and production.

How much funding has RYAM raised?

RYAM has raised a total of $70.5M across 2 funding rounds:

2024

Private Equity

$31.6M

Debt

$39M

Private Equity (2024): $31.6M with participation from SWEN Capital Partners

Debt (2024): $39M led by BNP Paribas, Lcl, SWEN Capital Partners, and Arkéa Banque Entreprises et Institutionnels

Key Investors in RYAM

SWEN Capital Partners

SWEN Capital Partners is a responsible investor specializing in private equity, infrastructure, and private debt, focused on creating sustainable value and offering multi-strategy investment solutions, including Tech for Good and Climate Impact initiatives.

BNP Paribas

BNP Paribas is a leading international banking group providing a broad range of financial services, including corporate and institutional banking, with a significant global presence and a commitment to sustainable finance and energy transition projects.

Lcl

Lcl is a French bank offering everyday banking, lending, savings, and insurance services for individuals and families, simplifying personal finance management and future planning.

What's next for RYAM?

The substantial enterprise-level funding and recent strategic investment indicate a strong growth trajectory for RYAM. This capital infusion is likely to accelerate the expansion of its production capabilities, further research and development into novel biomaterials, and potentially broaden its market reach. RYAM's commitment to sustainable technologies positions it well to capitalize on the increasing global demand for bio-based products and renewable energy solutions.

See full RYAM company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

ManufacturingMedical Devices & EquipmentRetailApparel & Accessories RetailTextiles & Apparel
ManufacturingMedical Devices & EquipmentDrug Stores & PharmaciesRetail
ManufacturingPlastic, Packaging & Containers
ManufacturingPlastic, Packaging & Containers

Frequently Asked Questions Regarding RYAM Financial Insights

What are the most recent funding rounds that RYAM has completed, and what were the funding rounds?
RYAM has recently completed 2 funding rounds: Debt on Nov 12, 2024, Private Equity on Nov 12, 2024.
What is the total amount of funding RYAM has raised to date?
RYAM has raised a total of $70.5M in funding to date.
How many funding rounds has RYAM completed?
RYAM has completed 2 funding rounds.
How much funding did RYAM raise in its most recent funding round?
RYAM raised $39M in its most recent funding round.
Who are the lead investors in RYAM's latest funding round?
The lead investor in RYAM's latest funding round was BNP Paribas. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in RYAM's history?
The largest funding round in RYAM's history was $39M.
See more information about RYAM